Skip to main content Skip to search Skip to main navigation
Flask High Quality Molecules
Truck Fast Delivery
Award Trusted by Researchers
Follow us: LinkedIn Contact Security

Aldehydes

  • High-purity Aldehydes
  • Extensive range of Aldehydes
  • Ideal for drug discovery applications and organic synthesis
  • Fast delivery and expert support
Aldehydes compounds are essential building blocks in pharmaceutical research. Our carefully curated selection offers diverse structures for SAR studies and lead optimization, ensuring quality and reliability for your projects.

Understanding Aldehydes in Modern Chemistry

Explore the critical role of Aldehydes in pharmaceutical development, medicinal chemistry research and organic chemistry.

Precision Chemistry

Precision Chemistry

Advanced synthesis techniques for superior quality compounds

Great Molecules for Chemical Diversity

Our catalogue of building blocks contains a diverse range of highly functionalised and decorated compounds. The 20 years of experience in supplying cutting-edge building blocks have given us the expertise to bring you the most exciting chemical motifs, adding chemical diversity to your projects.

Our diverse catalogue is tailored for medicinal chemistry, small molecule drug discovery and organic synthesis. Our unique range of Aldehydes adds value to any research project.

We constantly add to our catalogue; the latest additions include a range of new Aldehydes. We continue to bring you the latest and most exciting chemical compounds.

Quality Assurance

Quality Assurance

Every Aldehydes product in our portfolio undergoes rigorous quality control testing. Our building blocks are supplied with the highest purity standards. We provide complete analytical characterisation, including:

  • ¹H and ¹³C NMR spectroscopy for structural verification
  • HPLC chromatograms confirming purity levels
  • Certificate of Analysis available.
  • Standard purity of 95%
  • Specific purity available upon request.

Diverse Applications

Diverse Applications

From oncology to neuroscience, enabling next-generation therapeutics

Over 7500 Aldehydes in our catalogue
Found in over 5 FDA-approved drugs
95% of compounds available from stock

Aldehydes products in our portfolio

The aldehyde group occupies a distinctive position in medicinal chemistry, valued primarily as a reactive electrophilic carbonyl capable of forming reversible covalent bonds with biological nucleophiles. Aldehydes react with primary amines to form imines (Schiff bases), with thiols to form thiohemiacetals, and with lysine residues to form stabilised adducts, making them attractive warheads for reversible covalent inhibitor design. When positioned within a constrained molecular environment that provides additional stabilising interactions, the aldehyde warhead can deliver both high potency and acceptable selectivity. This has driven a growing interest in the aldehyde as a purposeful, tuneable electrophile in targeted covalent inhibitor programmes, particularly for protease and kinase targets where active-site geometry stabilises the covalent adduct. Aldehydes also serve as ubiquitous synthetic intermediates throughout pharmaceutical synthesis, occupying a central role in the construction of amine-containing drug scaffolds and in the elaboration of complex natural product-derived frameworks. Beyond final drug structures, the controlled reactivity of the aldehyde group makes it a reliable handle in bioconjugation, enabling site-selective conjugation to amine-bearing biomolecules through imine chemistry.

In organic synthesis, the aldehyde is one of the most versatile functional groups and participates in a broad range of fundamental named reactions. The Wittig reaction and its phosphonate variant, the Horner-Wadsworth-Emmons reaction, convert aldehydes to alkenes with control over olefin geometry, and are routinely employed in the synthesis of drug fragments containing extended conjugated systems. Reductive amination, using reducing agents such as sodium cyanoborohydride or sodium triacetoxyborohydride, converts aldehydes and amines directly to secondary amines via transient imine intermediates, and is among the most commonly applied C-N bond-forming reactions in pharmaceutical synthesis. The Grignard and organolithium additions to aldehydes provide rapid access to secondary alcohols, while the Pinnick oxidation converts aldehydes to carboxylic acids under mild, selective conditions. The Cannizzaro reaction enables disproportionation of non-enolisable aldehydes to the corresponding alcohol and acid, and the Knoevenagel condensation provides access to alpha,beta-unsaturated carbonyl systems of relevance to SAR diversification.

Emerging synthetic techniques are opening new avenues for the use of aldehydes. In photochemistry, visible-light hydrogen atom transfer (HAT) catalysis enables the generation of nucleophilic acyl radicals directly from the aldehydic C-H bond, providing access to diverse acyl products through radical addition to alkenes, alkynes, and SOMOphilic sulfone reagents without the need for prefunctionalisation or transition metal oxidants. Photoredox organocatalysis, combining enamine intermediates with single-electron oxidation, has enabled direct beta-alkylation of aldehydes, demonstrating the power of dual catalysis for enantioselective C-C bond formation at positions remote from the carbonyl. Electrochemically, aldehydes participate as substrates in cathodic reductive electrolysis, generating radical-anion intermediates that can be intercepted for C-C and C-heteroatom bond formation, while anodic approaches have enabled deformylative cross-coupling strategies that use the aldehyde as a traceless C1 unit.

Our catalogue of aldehydes spans aryl, heteroaryl, and alkyl structures . We offer aldehydes with additional substitution patterns and functional group handles to support medicinal chemistry programmes, late-stage diversification strategies, SAR investigations, and complex molecule synthesis.

Frequently Asked Questions

Common questions about our Aldehydes products.

The aldehyde group occupies a distinctive position in medicinal chemistry, valued primarily as a reactive electrophilic carbonyl capable of forming reversible covalent bonds with biological nucleophiles. Aldehydes react with primary amines to form imines, with thiols to form thiohemiacetals, and with lysine residues to form stabilised adducts, making them attractive warheads for reversible covalent inhibitor design.

When positioned within a constrained molecular environment that provides additional stabilising interactions, the aldehyde warhead can deliver both high potency and acceptable selectivity. This has driven growing interest in the aldehyde as a purposeful, tuneable electrophile in targeted covalent inhibitor programmes, particularly for protease and kinase targets where active-site geometry stabilises the covalent adduct.
The controlled reactivity of the aldehyde group makes it a reliable handle in bioconjugation, enabling site-selective conjugation to amine-bearing biomolecules through imine chemistry. Beyond final drug structures, aldehydes also serve as ubiquitous synthetic intermediates throughout pharmaceutical synthesis, occupying a central role in the construction of amine-containing drug scaffolds.
The Wittig reaction and its phosphonate variant, the Horner-Wadsworth-Emmons reaction, convert aldehydes to alkenes with control over olefin geometry, and are routinely employed in the synthesis of drug fragments containing extended conjugated systems. These transformations are among the most reliable methods for installing alkenes of defined geometry from an aldehyde precursor.
Reductive amination, using reducing agents such as sodium cyanoborohydride or sodium triacetoxyborohydride, converts aldehydes and amines directly to secondary amines via transient imine intermediates, and is among the most commonly applied C-N bond-forming reactions in pharmaceutical synthesis. This reaction exploits the same electrophilic reactivity that makes aldehydes useful as covalent warheads, but in a controlled, irreversible synthetic context.
Visible-light hydrogen atom transfer catalysis enables the generation of nucleophilic acyl radicals directly from the aldehydic C-H bond, providing access to diverse acyl products through radical addition to alkenes, alkynes, and SOMOphilic sulfone reagents without the need for prefunctionalisation or transition metal oxidants. Photoredox organocatalysis has also enabled direct beta-alkylation of aldehydes through dual catalysis for enantioselective C-C bond formation.

Still have questions?

Our technical support team is here to help with any inquiries about our Aldehydes products.